Skip to main content
Knight Therapeutics Inc. logo

Knight Therapeutics Inc. — Investor Relations & Filings

Ticker · GUD LEI · 549300LNW93V3HRS7610 TSX Wholesale and retail trade
Open in API
Filings indexed 213 across all filing types
Latest filing 2025-04-05 Environmental & Social …
Country CA Canada
Listing TSX GUD

About Knight Therapeutics Inc.

https://knighttx.com/

Knight Therapeutics Inc. is a specialty pharmaceutical company dedicated to the acquisition, in-licensing, out-licensing, marketing, and commercialization of innovative pharmaceutical products. The portfolio includes prescription drugs, over-the-counter medications, and biosimilars. Knight operates as a Pan-American (ex-US) entity, concentrating its commercial efforts on Canada and Latin America to deliver both innovative and branded generic products to these specific markets.

Recent filings

Filing Released Lang Actions
Other.pdf
Environmental & Social Information Classification · 1% confidence The document is a standalone compliance report prepared under the Fighting Against Forced Labour and Child Labour in Supply Chains Act covering policies, due diligence processes, risk assessments, training, remediation actions, and attestation for the fiscal year ending December 31, 2024. It focuses on social factors (forced labour and child labour) in the supply chain, fitting the definition of an Environmental & Social Information (ESG) report rather than a general annual or interim financial report. Hence it is classified as SR.
2025-04-05 English
Form of proxy - French.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a solicitation of proxies for the company’s Annual General Meeting on May 7, 2025. It provides a proxy voting form, instructions on how to appoint a proxy, voting recommendations, and methods for voting by phone or internet. These are materials sent to shareholders to request their votes at an AGM, which corresponds to a Proxy Solicitation & Information Statement.
2025-04-05 French
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is clearly a Form of Proxy for the company’s Annual General Meeting (AGM). It contains voting instructions, proxyholder appointment details, and solicitation language for shareholder votes. This aligns exactly with the ‘Proxy Solicitation & Information Statement’ category rather than an AGM presentation, earnings release, or other filings.
2025-04-05 English
Notice of meeting - French.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of the annual general meeting (AGM) with the agenda, proxy voting instructions, and reference to the attached management information circular for soliciting shareholder votes. This falls under proxy solicitation materials rather than being the AGM presentation itself or an earnings/legal report. Therefore it is classified as a Proxy Solicitation & Information Statement (PSI).
2025-04-05 French
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal Notice of the Annual General Meeting of shareholders, outlining the meeting date, agenda items (receipt of financial statements, election of directors, re-appointment of auditors, share purchase plan approval), voting instructions, proxy deadlines, and reference to the accompanying management information circular. This notice is a proxy solicitation document sent to shareholders to provide information and request their votes. It fits the definition of a Proxy Solicitation & Information Statement.
2025-04-05 English
Management information circular - French.pdf
Regulatory Filings
2025-04-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.